The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Conclusion:
Amlodipine lowered long-term gout risk compared with lisinopril or chlorthalidone. This finding may be useful in cases where gout risk is a principal concern among patients being treated for hypertension.
This trial is registered at clinicaltrials.gov, number: NCT00000542.
Source: Journal of Hypertension - Category: Cardiology Tags: ORIGINAL PAPERS: Treatment Source Type: research
More News: Atenolol | Cardiology | Clinical Trials | Coronary Heart Disease | Gout | Heart | Heart Attack | Heart Disease | Hypertension | Lisinopril | Norvasc | Women